Zelira Therapeutics Meets Primary Endpoints for Phase (1b/2a) Medicinal Cannabis Trial for Insomnia
•23 chronic insomnia patients treated with ZLT-101, Zelira’s proprietary and patented medicinalcannabis formulation, demonstrated statistically significant improvement in Insomnia SeverityIndex scores compared to placebo
•ZLT-101 therapy was well tolerated, with no serious adverse events reported
•Positive trial results an important milestone for Zelira
•Poised to launch world’s first clinically validated medicinal cannabis product for insomnia in 2020
•Expands Zelira’s product portfolio alongside the HOPETM product range
Here we go...
- Forums
- ASX - By Stock
- ZLD
- Ann: Trading Halt
Ann: Trading Halt, page-85
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.198M |
Open | High | Low | Value | Volume |
37.0¢ | 38.0¢ | 37.0¢ | $6.724K | 18.10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 649 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 560 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 649 | 0.370 |
1 | 1350 | 0.365 |
1 | 1400 | 0.360 |
1 | 12392 | 0.315 |
1 | 1700 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 560 | 1 |
0.390 | 2837 | 1 |
0.400 | 454 | 3 |
0.410 | 1000 | 1 |
0.440 | 6460 | 2 |
Last trade - 15.31pm 21/06/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online